查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968118

全球微创前列腺癌手术市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Prostate Cancer Minimally Invasive Surgery Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

微创前列腺癌手术市场预计将从 2025 年的 37.8 亿美元成长到 2034 年的 54.1 亿美元，2026 年至 2034 年的复合年增长率为 4.07%。

受前列腺癌发病率上升和微创手术需求增加的推动，全球微创前列腺癌手术市场正稳步成长。早期诊断意识提升、腹腔镜和机器人辅助手术技术的进步以及患者预后的改善，都显着促进了市场扩张。医院和专科诊所正在迅速采用先进的手术平台，以缩短住院时间、减少出血量并加快康復，从而提高患者满意度，并提升已开发国家和新兴国家医疗系统的手术效率。

关键成长要素包括男性人口老化、机器人手术系统的技术创新以及已开发国家有利的医疗保险报销政策。由于微创手术精度更高、术后併发症更少，外科医生越来越倾向于选择微创手术。此外，旨在改进手术视野和器械的持续研发活动正在增强市场渗透率。新兴地区医疗基础设施的发展为设备製造商和服务供应商创造了更大的机会。

展望未来，随着精准医疗和人工智慧的融合革新外科手术流程，市场预计将稳定扩张。癌症治疗投入的增加和筛检率的提高将进一步推动手术数量的成长。新兴经济体可望凭藉医疗服务覆盖范围的扩大和可支配收入的增加，展现强劲的成长潜力。随着技术的不断创新以及患者对微创治疗偏好的转变，市场有望实现永续的长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球微创前列腺癌手术市场：依治疗方法

  • 市场分析、洞察与预测
  • 腹腔镜手术
  • 机器人手术
  • 放射治疗
  • 冷冻疗法
  • 其他的

第五章：全球微创前列腺癌手术市场：依阶段划分

  • 市场分析、洞察与预测
  • 早期摄护腺癌（I期和II期）
  • 局部进行性摄护腺癌（III期）
  • 进行性前列腺癌（IV期）

第六章 全球微创前列腺癌手术市场：依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 专科诊所
  • 门诊手术中心

第七章 全球微创前列腺癌手术市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • AngioDynamics
    • B. Braun SE
    • Becton
    • Dickinson And Company
    • Ethicon Endo-Surgery Inc.（A Johnson & Johnson Company）
    • Intuitive Surgical
    • Medtronic
    • Olympus Corporation
    • Siemens Healthcare GmbH
    • Teleflex Incorporated
简介目录
Product Code: VMR112110245

The Prostate Cancer Minimally Invasive Surgery Market size is expected to reach USD 5.41 Billion in 2034 from USD 3.78 Billion (2025) growing at a CAGR of 4.07% during 2026-2034.

The Global Prostate Cancer Minimally Invasive Surgery Market is witnessing steady growth driven by the rising incidence of prostate cancer and growing preference for minimally invasive procedures. Increasing awareness about early diagnosis, advancements in laparoscopic and robotic-assisted surgical techniques, and improved patient outcomes are significantly supporting market expansion. Hospitals and specialty clinics are rapidly adopting advanced surgical platforms that reduce hospital stay, minimize blood loss, and ensure faster recovery, thereby enhancing patient satisfaction and procedural efficiency across developed and emerging healthcare systems.

Key growth drivers include the aging male population, technological innovations in robotic surgical systems, and favorable reimbursement policies in advanced economies. Surgeons are increasingly opting for minimally invasive approaches due to enhanced precision and reduced post-operative complications. Additionally, continuous research and development activities aimed at improving surgical visualization and instrumentation are strengthening market penetration. Healthcare infrastructure upgrades in emerging regions are further creating substantial opportunities for device manufacturers and service providers.

Looking ahead, the market is expected to expand consistently as precision medicine and artificial intelligence integration reshape surgical workflows. Increased investments in oncology care, combined with rising screening rates, will further fuel procedural volumes. Emerging economies are projected to offer strong growth potential due to expanding healthcare access and rising disposable incomes. As innovation continues and patient preference shifts toward less invasive treatments, the market is poised for sustainable long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Procedure

  • Laparoscopic Surgery
  • Robotic Surgery
  • Radiation Therapy
  • Cryosurgery
  • Others

By Stage

  • Early-stage Prostate Cancer (Stages I And II)
  • Locally Advanced Prostate Cancer (Stage III)
  • Advanced Prostate Cancer (Stage IV)

By End-user

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers

COMPANIES PROFILED

  • AngioDynamics, B Braun SE, Becton, Dickinson and Company, Ethicon EndoSurgery Inc a Johnson Johnson company, Intuitive Surgical, Medtronic, Olympus Corporation, Siemens Healthcare GmbH, Teleflex Incorporated
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET: BY PROCEDURE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Procedure
  • 4.2. Laparoscopic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Robotic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cryosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET: BY STAGE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Stage
  • 5.2. Early-stage Prostate Cancer (Stages I And II) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Locally Advanced Prostate Cancer (Stage III) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Advanced Prostate Cancer (Stage IV) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Procedure
    • 7.2.2 By Stage
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Procedure
    • 7.3.2 By Stage
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Procedure
    • 7.4.2 By Stage
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Procedure
    • 7.5.2 By Stage
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Procedure
    • 7.6.2 By Stage
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PROSTATE CANCER MINIMALLY INVASIVE SURGERY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 AngioDynamics
    • 9.2.2 B. Braun SE
    • 9.2.3 Becton
    • 9.2.4 Dickinson And Company
    • 9.2.5 Ethicon Endo-Surgery Inc. (A Johnson & Johnson Company)
    • 9.2.6 Intuitive Surgical
    • 9.2.7 Medtronic
    • 9.2.8 Olympus Corporation
    • 9.2.9 Siemens Healthcare GmbH
    • 9.2.10 Teleflex Incorporated